New insights into vitamin K biology with relevance to cancer
JE Welsh, MJ Bak, CJ Narvaez - Trends in molecular medicine, 2022 - cell.com
Phylloquinone (vitamin K1) and menaquinones (vitamin K2 family) are essential for post-
translational γ-carboxylation of a small number of proteins, including clotting factors. These …
translational γ-carboxylation of a small number of proteins, including clotting factors. These …
The Potential of Vitamin K as a Regulatory Factor of Bone Metabolism—A Review
H Wang, Y Ma - Nutrients, 2023 - mdpi.com
Vitamin K (VK), a fat-soluble vitamin, is essential for the clotting of blood because of its role
in the production of clotting factors in the liver. Moreover, researchers continue to explore the …
in the production of clotting factors in the liver. Moreover, researchers continue to explore the …
Vitamin A, D, E, and K as Matrix Metalloproteinase-2/9 Regulators That Affect Expression and Enzymatic Activity
HVT Vo, YT Nguyen, N Kim, HJ Lee - International journal of molecular …, 2023 - mdpi.com
Fat-soluble vitamins (vitamin A, D, E, and K) assume a pivotal role in maintaining human
homeostasis by virtue of their enzymatic functions. The daily inclusion of these vitamins is …
homeostasis by virtue of their enzymatic functions. The daily inclusion of these vitamins is …
[HTML][HTML] Unlocking the potential of 1, 4-naphthoquinones: A comprehensive review of their anticancer properties
E Angulo-Elizari, A Henriquez-Figuereo… - European Journal of …, 2024 - Elsevier
Cancer encompasses a group of pathologies with common characteristics, high incidence,
and prevalence in all countries. Although there are treatments available for this disease …
and prevalence in all countries. Although there are treatments available for this disease …
In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto …
G Bajraktari-Sylejmani, JS Oster, J Burhenne… - Archives of …, 2024 - Springer
The most important dose-limiting factor of the anthracycline idarubicin is the high risk of
cardiotoxicity, in which the secondary alcohol metabolite idarubicinol plays an important …
cardiotoxicity, in which the secondary alcohol metabolite idarubicinol plays an important …
[HTML][HTML] Vitamin D and Its Receptors in Cervical Cancer
H Dong, S Chen, X Liang, Q Cai, X Zhang, J Xie… - Journal of …, 2024 - ncbi.nlm.nih.gov
Several studies have investigated the relationship between vitamin D (VD) and its receptors
(VDR) and the risk of cervical cancer. However, the underlying mechanisms that underpin …
(VDR) and the risk of cervical cancer. However, the underlying mechanisms that underpin …
PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC
A Farina, S Tartaglione, A Preziosi, P Mancini… - International Journal of …, 2024 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC) represents a highly aggressive malignancy with
a lack of reliable diagnostic biomarkers. Protein induced by vitamin K absence (PIVKA-II) is …
a lack of reliable diagnostic biomarkers. Protein induced by vitamin K absence (PIVKA-II) is …
Anticancer and Chemosensitizing Effects of Menadione-Containing Peptide-Targeted Solid Lipid Nanoparticles
M Zoughaib, TN Pashirova, V Nikolaeva… - Journal of …, 2024 - Elsevier
Vitamin K derivatives such as menadione (MD) have been recognized as promising redox-
modulating and chemosensitizing agents for anticancer therapy, however, their cellular …
modulating and chemosensitizing agents for anticancer therapy, however, their cellular …
Effect of asciminib and vitamin K2 on Abelson tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells
S Okabe, A Gotoh - BMC cancer, 2023 - Springer
Background Abelson (ABL) tyrosine kinase inhibitors (TKIs) are effective against chronic
myeloid leukemia (CML); however, many patients develop resistance during ABL TKI …
myeloid leukemia (CML); however, many patients develop resistance during ABL TKI …
In vivo anticancer study of sodium 2‐[(4‐oxidobenzylidene) amino]‐6H‐1, 3, 4‐thiadiazine‐5‐olate against Ehrlich ascites carcinoma via targeting PI3K/mTOR …
YW Rizzk, IM El‐Deen, ME Behery… - Chemical Biology & …, 2024 - Wiley Online Library
Thiadiazine‐based components have gained the attention as they afford significant
intervention for cancer therapy. We aimed at assessing the in vivo antitumor activity of …
intervention for cancer therapy. We aimed at assessing the in vivo antitumor activity of …